Compare MCHB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCHB | VKTX |
|---|---|---|
| Founded | 1905 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.4B |
| IPO Year | N/A | 2014 |
| Metric | MCHB | VKTX |
|---|---|---|
| Price | $14.29 | $32.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $14.50 | ★ $88.00 |
| AVG Volume (30 Days) | 342.4K | ★ 2.9M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.61 | N/A |
| Revenue Next Year | $5.40 | N/A |
| P/E Ratio | $12.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.82 | $18.92 |
| 52 Week High | $16.02 | $43.15 |
| Indicator | MCHB | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.36 | 54.81 |
| Support Level | $14.01 | $30.73 |
| Resistance Level | $15.67 | $35.64 |
| Average True Range (ATR) | 0.54 | 1.83 |
| MACD | -0.12 | 0.56 |
| Stochastic Oscillator | 13.27 | 65.91 |
Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. Mechanics' retail banking products include personal checking, savings and loan products (including credit card, home equity, home mortgage and secured/unsecured loans), online banking and wealth management services (including trust and estate, investment management and financial planning services). Mechanics' banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing and loans guaranteed by the Small Business Administration.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.